Given Imaging Ltd. (Nasdaq: GIVN; TASE: GIVN) announced that it has received marketing clearance from the US Food and Drug Administration (FDA) for its PillCam SB (small bowel) 2 video capsule and Rapid 5 software, which supports its next generation of products.
The company said that the new capsule has the same dimensions as its flagship PillCam SB and captures nearly twice the mucosal area per image compared with PillCam SB. PillCam SB 2 also provides automatic light control for optimal illumination of each image.
The new Rapid 5 software supports the company's next generation of PillCam video capsules, two of which are awaiting FDA approval. It also includes new tools to improve diagnosis by doctors.
Given Imaging CEO and president Nachum (Homi) Shamir said, "We're excited to introduce PillCam SB 2, our next generation small bowel video capsule, together with Rapid 5, an enhanced version of our proprietary software. These new products are at the forefront of capsule endoscopy technology and demonstrate our strategic leadership and commitment to innovation."
Given Imaging's new products will be introduced at the Digestive Disease Week exhibition in Washington and they will be available to customers in the second half of 2007.
Published by Globes [online], Israel business news - www.globes.co.il - on May 17, 2007
© Copyright of Globes Publisher Itonut (1983) Ltd. 2007